The Systemic Immune Inflammation Index (SII) Combined with the Creatinine-to-Cystatin C Ratio (Cre/CysC) Predicts Sarcopenia in Patients with Liver Cirrhosis Complicated with Primary Hepatocellular Carcinoma

References

• Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, Nakagomi R, Kondo M, Nakatsuka T, Minami T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63(1):131–40. doi:10.1016/j.jhep.2015.02.031.
   PubMed Web of Science ®Google Scholar
• Paternostro R, Bardach C, Hofer BS, Scheiner B, Schwabl P, Asenbaum U, Ba-Ssalamah A, Scharitzer M, Bucscis T, Simbrunner B, et al. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension. Liver Int. 2021;41(4):799–809. doi:10.1111/liv.14758.
   PubMed Web of Science ®Google Scholar
• Beer L, Bastati N, Ba-Ssalamah A, Pötter-Lang S, Lampichler K, Bican Y, Lauber D, Hodge J, Binter T, Pomej K, et al. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease. Liver Int. 2020;40(11):2797–807. doi:10.1111/liv.14648.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601. doi:10.1093/ageing/afz046.
   PubMed Web of Science ®Google Scholar
• Koya S, Kawaguchi T, Hashida R, Hirota K, Bekki M, Goto E, Yamada M, Sugimoto M, Hayashi S, Goshima N, et al. Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization. J Gastroenterol Hepatol. 2019;34(3):580–8. doi:10.1111/jgh.14538.
   PubMed Web of Science ®Google Scholar
• Wing SS, Lecker SH, Jagoe RT. Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks. Crit Rev Clin Lab Sci. 2011;48(2):49–70. doi:10.3109/10408363.2011.586171.
   PubMed Web of Science ®Google Scholar
• Huang JB, Sang T, Quan XQ, et al. Advances in systemic immune-inflammation index in peripheral blood of elder patients with gastrointestinal cancer[J].The. Chinese Electron J Geriatr Res. 2019;6(4):35–9. doi:10.3877/cma.j.issn.2095-8757.2019.04.008.
   Google Scholar
• Zhao W-Y, Zhang Y, Hou L-S, Xia X, Ge M-L, Liu X-L, Yue J-R, Dong B-R. The association between systemic inflammatory markers and sarcopenia: Results from the West China Health and Aging Trend Study (WCHAT). Arch Gerontol Geriatr. 2021;92:104262. doi:10.1016/j.archger.2020.104262.
   PubMed Web of Science ®Google Scholar
• Hirai K, Tanaka A, Homma T, Goto Y, Akimoto K, Uno T, Yoshitaka U, Miyata Y, Inoue H, Ohta S, et al. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease. Clin Nutr. 2021;40(3):1274–80. doi:10.1016/j.clnu.2020.08.010.
   PubMed Web of Science ®Google Scholar
• Lin Y-L, Chen S-Y, Lai Y-H, Wang C-H, Kuo C-H, Liou H-H, Hsu B-G. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease. Clin Nutr. 2020;39(8):2435–41. doi:10.1016/j.clnu.2019.10.027.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2019;27(11):846–65. doi:10.3760/cma.j.issn.1007-3418.2019.11.008.
   PubMedGoogle Scholar
• National Cancer Center Liver Cancer Expert Committee of National Cancer Quality Control Center. Quality control index for standardized diagnosis and treatment of primary liver cancer in China (2022 edition). Zhonghua Zhong Liu Za Zhi. 2022;44(7):600–8. doi:10.3760/cma.j.cn112152-20220418-00265.
   PubMedGoogle Scholar
• Satala CB, Jung I, Kobori L, Kovacs Z, Fodor D, Szodorai R, Gurzu S. Benefits of the 8th American Joint Committee on cancer system for hepatocellular carcinoma staging. J Gastrointest Cancer. 2021;52(1):243–8. doi:10.1007/s12029-020-00394-z.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res. 2016;46(10):951–63. doi:10.1111/hepr.12774.
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun H-C, Wang Z, Cong W-M, Wang J-H, Zeng M-S, Yang J-M, Bie P, Liu L-X, Wen T-F, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition). Liver Cancer. 2018;7(3):235–60. doi:10.1159/000488035.
   PubMed Web of Science ®Google Scholar
• Buckinx F, Landi F, Cesari M, Fielding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle. 2018;9(2):269–78. doi:10.1002/jcsm.12268.
   PubMed Web of Science ®Google Scholar
• Xiao HJ, Ye Q, Zhang M, Qi YM, Han T, Wang X. Risk factors of cirrhosis combined with sarcopenia and their impact on clinical outcomes. Zhonghua Gan Zang Bing Za Zhi. 2020;28(1):53–7. doi: 10.3760/cma.j.issn.1007-3418.2020.01.013.
   PubMedGoogle Scholar
• Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65(6):1232–44. doi:10.1016/j.jhep.2016.07.040.
   PubMed Web of Science ®Google Scholar
• Tuttle CSL, Thang LAN, Maier AB. Markers of inflammation and their association with muscle strength and mass: A systematic review and meta-analysis. Ageing Res Rev. 2020;64:101185. doi:10.1016/j.arr.2020.101185.
   PubMed Web of Science ®Google Scholar
• Shaul ME, Fridlender ZG. Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol. 2019;16(10):601–20. doi:10.1038/s41571-019-0222-4.
   PubMed Web of Science ®Google Scholar
• Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021;14(1):173. doi:10.1186/s13045-021-01187-y.
   PubMed Web of Science ®Google Scholar
• Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK. The platelet lifeline to cancer: Challenges and opportunities. Cancer Cell. 2018;33(6):965–83. doi:10.1016/j.ccell.2018.03.002.
   PubMed Web of Science ®Google Scholar
• Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, Heilberg IP. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3(2):348–54. doi:10.2215/CJN.02870707.
   PubMed Web of Science ®Google Scholar
• Viollet L, Gailey S, Thornton DJ, Friedman NR, Flanigan KM, Mahan JD, Mendell JR. Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy. Muscle Nerve. 2009;40(3):438–42. doi:10.1002/mus.21420.
   PubMed Web of Science ®Google Scholar
• Barreto EF, Poyant JO, Coville HH, Dierkhising RA, Kennedy CC, Gajic O, Nystrom EM, Takahashi N, Moynagh MR, Kashani KB, et al. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers. Clin Nutr. 2019;38(3):1362–7. doi:10.1016/j.clnu.2018.05.031.
   PubMed Web of Science ®Google Scholar
• Fu X, Tian Z, Wen S, Sun H, Thapa S, Xiong H, Liu H, Li L, Yu S. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer. Nutrition. 2021;82:111032. doi:10.1016/j.nut.2020.111032.
   PubMed Web of Science ®Google Scholar